An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Dr. Roumen Milev, Queen's University
ClinicalTrials.gov Identifier:
NCT00520507
First received: August 22, 2007
Last updated: December 14, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
No publications provided by Queen's University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):